Global Human Interleukin-2 (IL-2) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The main component of adipoiol is recombinant human interleukin, which is a polypeptide immune enhancer.It can induce the secretion of interferon and various cytokines.Clinically, it is used for adjuvant therapy of tumor and treatment of cancerous thorax and ascites.
LPI (LP Information)' newest research report, the “Human Interleukin-2 (IL-2) Industry Forecast” looks at past sales and reviews total world Human Interleukin-2 (IL-2) sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Interleukin-2 (IL-2) sales for 2023 through 2029. With Human Interleukin-2 (IL-2) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Interleukin-2 (IL-2) industry.
This Insight Report provides a comprehensive analysis of the global Human Interleukin-2 (IL-2) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Interleukin-2 (IL-2) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Interleukin-2 (IL-2) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Interleukin-2 (IL-2) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Interleukin-2 (IL-2).
The global Human Interleukin-2 (IL-2) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Human Interleukin-2 (IL-2) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Human Interleukin-2 (IL-2) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Human Interleukin-2 (IL-2) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Human Interleukin-2 (IL-2) players cover Roche, BMS, Schering-Plough, AbbVie Inc, Alkermes Plc, APT Therapeutics, Mabtech Limited, Philogen and Sinopharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Interleukin-2 (IL-2) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Human Interleukin-2 (IL-2) market?
What factors are driving Human Interleukin-2 (IL-2) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Interleukin-2 (IL-2) market opportunities vary by end market size?
How does Human Interleukin-2 (IL-2) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The main component of adipoiol is recombinant human interleukin, which is a polypeptide immune enhancer.It can induce the secretion of interferon and various cytokines.Clinically, it is used for adjuvant therapy of tumor and treatment of cancerous thorax and ascites.
LPI (LP Information)' newest research report, the “Human Interleukin-2 (IL-2) Industry Forecast” looks at past sales and reviews total world Human Interleukin-2 (IL-2) sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Interleukin-2 (IL-2) sales for 2023 through 2029. With Human Interleukin-2 (IL-2) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Interleukin-2 (IL-2) industry.
This Insight Report provides a comprehensive analysis of the global Human Interleukin-2 (IL-2) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Interleukin-2 (IL-2) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Interleukin-2 (IL-2) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Interleukin-2 (IL-2) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Interleukin-2 (IL-2).
The global Human Interleukin-2 (IL-2) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Human Interleukin-2 (IL-2) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Human Interleukin-2 (IL-2) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Human Interleukin-2 (IL-2) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Human Interleukin-2 (IL-2) players cover Roche, BMS, Schering-Plough, AbbVie Inc, Alkermes Plc, APT Therapeutics, Mabtech Limited, Philogen and Sinopharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Interleukin-2 (IL-2) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 50000 U
- 100000 U
- 200000 U
- 500000 U
- 1 Million U
- 2 Million U
- Recombinant Interferon
- Recombinant Interleukin
- Natural Biological Products
- Poison Immune
- Gene Therapy
- Monoclonal Antibody
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- BMS
- Schering-Plough
- AbbVie Inc
- Alkermes Plc
- APT Therapeutics
- Mabtech Limited
- Philogen
- Sinopharm
- Jiangsu Jinsili Pharmaceutical
- Shenyang Sansheng Pharmaceutical
- Beijing Shuanglu Pharmaceutical
- Shandong Quangang Pharmaceutical
- Shanghai Huaxin Biological high-tech
- Beijing Yuance Pharmaceutical
- Beijing Sihuan Biological Pharmaceutical
- Beijing Sanyuan Gene Pharmaceutical
- Shenzhen Kexing Biological Engineering
- Shanghai Sanwei Biotechnology
- Xiamen Tebao Biological Engineering
- Chengdu huashen Biotechnology
- Shanghai Pharma Group
- Guangdong Xinghao Pharmaceutical
What is the 10-year outlook for the global Human Interleukin-2 (IL-2) market?
What factors are driving Human Interleukin-2 (IL-2) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Interleukin-2 (IL-2) market opportunities vary by end market size?
How does Human Interleukin-2 (IL-2) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Interleukin-2 (IL-2) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Interleukin-2 (IL-2) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Interleukin-2 (IL-2) by Country/Region, 2018, 2022 & 2029
2.2 Human Interleukin-2 (IL-2) Segment by Type
2.2.1 50000 U
2.2.2 100000 U
2.2.3 200000 U
2.2.4 500000 U
2.2.5 1 Million U
2.2.6 2 Million U
2.3 Human Interleukin-2 (IL-2) Sales by Type
2.3.1 Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
2.3.2 Global Human Interleukin-2 (IL-2) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Interleukin-2 (IL-2) Sale Price by Type (2018-2023)
2.4 Human Interleukin-2 (IL-2) Segment by Application
2.4.1 Recombinant Interferon
2.4.2 Recombinant Interleukin
2.4.3 Natural Biological Products
2.4.4 Poison Immune
2.4.5 Gene Therapy
2.4.6 Monoclonal Antibody
2.5 Human Interleukin-2 (IL-2) Sales by Application
2.5.1 Global Human Interleukin-2 (IL-2) Sale Market Share by Application (2018-2023)
2.5.2 Global Human Interleukin-2 (IL-2) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Interleukin-2 (IL-2) Sale Price by Application (2018-2023)
3 GLOBAL HUMAN INTERLEUKIN-2 (IL-2) BY COMPANY
3.1 Global Human Interleukin-2 (IL-2) Breakdown Data by Company
3.1.1 Global Human Interleukin-2 (IL-2) Annual Sales by Company (2018-2023)
3.1.2 Global Human Interleukin-2 (IL-2) Sales Market Share by Company (2018-2023)
3.2 Global Human Interleukin-2 (IL-2) Annual Revenue by Company (2018-2023)
3.2.1 Global Human Interleukin-2 (IL-2) Revenue by Company (2018-2023)
3.2.2 Global Human Interleukin-2 (IL-2) Revenue Market Share by Company (2018-2023)
3.3 Global Human Interleukin-2 (IL-2) Sale Price by Company
3.4 Key Manufacturers Human Interleukin-2 (IL-2) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Interleukin-2 (IL-2) Product Location Distribution
3.4.2 Players Human Interleukin-2 (IL-2) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN INTERLEUKIN-2 (IL-2) BY GEOGRAPHIC REGION
4.1 World Historic Human Interleukin-2 (IL-2) Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Interleukin-2 (IL-2) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Interleukin-2 (IL-2) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Interleukin-2 (IL-2) Market Size by Country/Region (2018-2023)
4.2.1 Global Human Interleukin-2 (IL-2) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Interleukin-2 (IL-2) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Interleukin-2 (IL-2) Sales Growth
4.4 APAC Human Interleukin-2 (IL-2) Sales Growth
4.5 Europe Human Interleukin-2 (IL-2) Sales Growth
4.6 Middle East & Africa Human Interleukin-2 (IL-2) Sales Growth
5 AMERICAS
5.1 Americas Human Interleukin-2 (IL-2) Sales by Country
5.1.1 Americas Human Interleukin-2 (IL-2) Sales by Country (2018-2023)
5.1.2 Americas Human Interleukin-2 (IL-2) Revenue by Country (2018-2023)
5.2 Americas Human Interleukin-2 (IL-2) Sales by Type
5.3 Americas Human Interleukin-2 (IL-2) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Interleukin-2 (IL-2) Sales by Region
6.1.1 APAC Human Interleukin-2 (IL-2) Sales by Region (2018-2023)
6.1.2 APAC Human Interleukin-2 (IL-2) Revenue by Region (2018-2023)
6.2 APAC Human Interleukin-2 (IL-2) Sales by Type
6.3 APAC Human Interleukin-2 (IL-2) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Interleukin-2 (IL-2) by Country
7.1.1 Europe Human Interleukin-2 (IL-2) Sales by Country (2018-2023)
7.1.2 Europe Human Interleukin-2 (IL-2) Revenue by Country (2018-2023)
7.2 Europe Human Interleukin-2 (IL-2) Sales by Type
7.3 Europe Human Interleukin-2 (IL-2) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Interleukin-2 (IL-2) by Country
8.1.1 Middle East & Africa Human Interleukin-2 (IL-2) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Interleukin-2 (IL-2) Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Interleukin-2 (IL-2) Sales by Type
8.3 Middle East & Africa Human Interleukin-2 (IL-2) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Interleukin-2 (IL-2)
10.3 Manufacturing Process Analysis of Human Interleukin-2 (IL-2)
10.4 Industry Chain Structure of Human Interleukin-2 (IL-2)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Interleukin-2 (IL-2) Distributors
11.3 Human Interleukin-2 (IL-2) Customer
12 WORLD FORECAST REVIEW FOR HUMAN INTERLEUKIN-2 (IL-2) BY GEOGRAPHIC REGION
12.1 Global Human Interleukin-2 (IL-2) Market Size Forecast by Region
12.1.1 Global Human Interleukin-2 (IL-2) Forecast by Region (2024-2029)
12.1.2 Global Human Interleukin-2 (IL-2) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Interleukin-2 (IL-2) Forecast by Type
12.7 Global Human Interleukin-2 (IL-2) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.1.3 Roche Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 BMS
13.2.1 BMS Company Information
13.2.2 BMS Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.2.3 BMS Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BMS Main Business Overview
13.2.5 BMS Latest Developments
13.3 Schering-Plough
13.3.1 Schering-Plough Company Information
13.3.2 Schering-Plough Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.3.3 Schering-Plough Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Schering-Plough Main Business Overview
13.3.5 Schering-Plough Latest Developments
13.4 AbbVie Inc
13.4.1 AbbVie Inc Company Information
13.4.2 AbbVie Inc Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.4.3 AbbVie Inc Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AbbVie Inc Main Business Overview
13.4.5 AbbVie Inc Latest Developments
13.5 Alkermes Plc
13.5.1 Alkermes Plc Company Information
13.5.2 Alkermes Plc Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.5.3 Alkermes Plc Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Alkermes Plc Main Business Overview
13.5.5 Alkermes Plc Latest Developments
13.6 APT Therapeutics
13.6.1 APT Therapeutics Company Information
13.6.2 APT Therapeutics Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.6.3 APT Therapeutics Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 APT Therapeutics Main Business Overview
13.6.5 APT Therapeutics Latest Developments
13.7 Mabtech Limited
13.7.1 Mabtech Limited Company Information
13.7.2 Mabtech Limited Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.7.3 Mabtech Limited Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mabtech Limited Main Business Overview
13.7.5 Mabtech Limited Latest Developments
13.8 Philogen
13.8.1 Philogen Company Information
13.8.2 Philogen Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.8.3 Philogen Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Philogen Main Business Overview
13.8.5 Philogen Latest Developments
13.9 Sinopharm
13.9.1 Sinopharm Company Information
13.9.2 Sinopharm Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.9.3 Sinopharm Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sinopharm Main Business Overview
13.9.5 Sinopharm Latest Developments
13.10 Jiangsu Jinsili Pharmaceutical
13.10.1 Jiangsu Jinsili Pharmaceutical Company Information
13.10.2 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.10.3 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangsu Jinsili Pharmaceutical Main Business Overview
13.10.5 Jiangsu Jinsili Pharmaceutical Latest Developments
13.11 Shenyang Sansheng Pharmaceutical
13.11.1 Shenyang Sansheng Pharmaceutical Company Information
13.11.2 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.11.3 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shenyang Sansheng Pharmaceutical Main Business Overview
13.11.5 Shenyang Sansheng Pharmaceutical Latest Developments
13.12 Beijing Shuanglu Pharmaceutical
13.12.1 Beijing Shuanglu Pharmaceutical Company Information
13.12.2 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.12.3 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Beijing Shuanglu Pharmaceutical Main Business Overview
13.12.5 Beijing Shuanglu Pharmaceutical Latest Developments
13.13 Shandong Quangang Pharmaceutical
13.13.1 Shandong Quangang Pharmaceutical Company Information
13.13.2 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.13.3 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shandong Quangang Pharmaceutical Main Business Overview
13.13.5 Shandong Quangang Pharmaceutical Latest Developments
13.14 Shanghai Huaxin Biological high-tech
13.14.1 Shanghai Huaxin Biological high-tech Company Information
13.14.2 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.14.3 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shanghai Huaxin Biological high-tech Main Business Overview
13.14.5 Shanghai Huaxin Biological high-tech Latest Developments
13.15 Beijing Yuance Pharmaceutical
13.15.1 Beijing Yuance Pharmaceutical Company Information
13.15.2 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.15.3 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Beijing Yuance Pharmaceutical Main Business Overview
13.15.5 Beijing Yuance Pharmaceutical Latest Developments
13.16 Beijing Sihuan Biological Pharmaceutical
13.16.1 Beijing Sihuan Biological Pharmaceutical Company Information
13.16.2 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.16.3 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Beijing Sihuan Biological Pharmaceutical Main Business Overview
13.16.5 Beijing Sihuan Biological Pharmaceutical Latest Developments
13.17 Beijing Sanyuan Gene Pharmaceutical
13.17.1 Beijing Sanyuan Gene Pharmaceutical Company Information
13.17.2 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.17.3 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Beijing Sanyuan Gene Pharmaceutical Main Business Overview
13.17.5 Beijing Sanyuan Gene Pharmaceutical Latest Developments
13.18 Shenzhen Kexing Biological Engineering
13.18.1 Shenzhen Kexing Biological Engineering Company Information
13.18.2 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.18.3 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Shenzhen Kexing Biological Engineering Main Business Overview
13.18.5 Shenzhen Kexing Biological Engineering Latest Developments
13.19 Shanghai Sanwei Biotechnology
13.19.1 Shanghai Sanwei Biotechnology Company Information
13.19.2 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.19.3 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Shanghai Sanwei Biotechnology Main Business Overview
13.19.5 Shanghai Sanwei Biotechnology Latest Developments
13.20 Xiamen Tebao Biological Engineering
13.20.1 Xiamen Tebao Biological Engineering Company Information
13.20.2 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.20.3 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Xiamen Tebao Biological Engineering Main Business Overview
13.20.5 Xiamen Tebao Biological Engineering Latest Developments
13.21 Chengdu huashen Biotechnology
13.21.1 Chengdu huashen Biotechnology Company Information
13.21.2 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.21.3 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Chengdu huashen Biotechnology Main Business Overview
13.21.5 Chengdu huashen Biotechnology Latest Developments
13.22 Shanghai Pharma Group
13.22.1 Shanghai Pharma Group Company Information
13.22.2 Shanghai Pharma Group Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.22.3 Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Shanghai Pharma Group Main Business Overview
13.22.5 Shanghai Pharma Group Latest Developments
13.23 Guangdong Xinghao Pharmaceutical
13.23.1 Guangdong Xinghao Pharmaceutical Company Information
13.23.2 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.23.3 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Guangdong Xinghao Pharmaceutical Main Business Overview
13.23.5 Guangdong Xinghao Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Interleukin-2 (IL-2) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Interleukin-2 (IL-2) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Interleukin-2 (IL-2) by Country/Region, 2018, 2022 & 2029
2.2 Human Interleukin-2 (IL-2) Segment by Type
2.2.1 50000 U
2.2.2 100000 U
2.2.3 200000 U
2.2.4 500000 U
2.2.5 1 Million U
2.2.6 2 Million U
2.3 Human Interleukin-2 (IL-2) Sales by Type
2.3.1 Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
2.3.2 Global Human Interleukin-2 (IL-2) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Interleukin-2 (IL-2) Sale Price by Type (2018-2023)
2.4 Human Interleukin-2 (IL-2) Segment by Application
2.4.1 Recombinant Interferon
2.4.2 Recombinant Interleukin
2.4.3 Natural Biological Products
2.4.4 Poison Immune
2.4.5 Gene Therapy
2.4.6 Monoclonal Antibody
2.5 Human Interleukin-2 (IL-2) Sales by Application
2.5.1 Global Human Interleukin-2 (IL-2) Sale Market Share by Application (2018-2023)
2.5.2 Global Human Interleukin-2 (IL-2) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Interleukin-2 (IL-2) Sale Price by Application (2018-2023)
3 GLOBAL HUMAN INTERLEUKIN-2 (IL-2) BY COMPANY
3.1 Global Human Interleukin-2 (IL-2) Breakdown Data by Company
3.1.1 Global Human Interleukin-2 (IL-2) Annual Sales by Company (2018-2023)
3.1.2 Global Human Interleukin-2 (IL-2) Sales Market Share by Company (2018-2023)
3.2 Global Human Interleukin-2 (IL-2) Annual Revenue by Company (2018-2023)
3.2.1 Global Human Interleukin-2 (IL-2) Revenue by Company (2018-2023)
3.2.2 Global Human Interleukin-2 (IL-2) Revenue Market Share by Company (2018-2023)
3.3 Global Human Interleukin-2 (IL-2) Sale Price by Company
3.4 Key Manufacturers Human Interleukin-2 (IL-2) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Interleukin-2 (IL-2) Product Location Distribution
3.4.2 Players Human Interleukin-2 (IL-2) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN INTERLEUKIN-2 (IL-2) BY GEOGRAPHIC REGION
4.1 World Historic Human Interleukin-2 (IL-2) Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Interleukin-2 (IL-2) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Interleukin-2 (IL-2) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Interleukin-2 (IL-2) Market Size by Country/Region (2018-2023)
4.2.1 Global Human Interleukin-2 (IL-2) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Interleukin-2 (IL-2) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Interleukin-2 (IL-2) Sales Growth
4.4 APAC Human Interleukin-2 (IL-2) Sales Growth
4.5 Europe Human Interleukin-2 (IL-2) Sales Growth
4.6 Middle East & Africa Human Interleukin-2 (IL-2) Sales Growth
5 AMERICAS
5.1 Americas Human Interleukin-2 (IL-2) Sales by Country
5.1.1 Americas Human Interleukin-2 (IL-2) Sales by Country (2018-2023)
5.1.2 Americas Human Interleukin-2 (IL-2) Revenue by Country (2018-2023)
5.2 Americas Human Interleukin-2 (IL-2) Sales by Type
5.3 Americas Human Interleukin-2 (IL-2) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Interleukin-2 (IL-2) Sales by Region
6.1.1 APAC Human Interleukin-2 (IL-2) Sales by Region (2018-2023)
6.1.2 APAC Human Interleukin-2 (IL-2) Revenue by Region (2018-2023)
6.2 APAC Human Interleukin-2 (IL-2) Sales by Type
6.3 APAC Human Interleukin-2 (IL-2) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Interleukin-2 (IL-2) by Country
7.1.1 Europe Human Interleukin-2 (IL-2) Sales by Country (2018-2023)
7.1.2 Europe Human Interleukin-2 (IL-2) Revenue by Country (2018-2023)
7.2 Europe Human Interleukin-2 (IL-2) Sales by Type
7.3 Europe Human Interleukin-2 (IL-2) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Interleukin-2 (IL-2) by Country
8.1.1 Middle East & Africa Human Interleukin-2 (IL-2) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Interleukin-2 (IL-2) Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Interleukin-2 (IL-2) Sales by Type
8.3 Middle East & Africa Human Interleukin-2 (IL-2) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Interleukin-2 (IL-2)
10.3 Manufacturing Process Analysis of Human Interleukin-2 (IL-2)
10.4 Industry Chain Structure of Human Interleukin-2 (IL-2)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Interleukin-2 (IL-2) Distributors
11.3 Human Interleukin-2 (IL-2) Customer
12 WORLD FORECAST REVIEW FOR HUMAN INTERLEUKIN-2 (IL-2) BY GEOGRAPHIC REGION
12.1 Global Human Interleukin-2 (IL-2) Market Size Forecast by Region
12.1.1 Global Human Interleukin-2 (IL-2) Forecast by Region (2024-2029)
12.1.2 Global Human Interleukin-2 (IL-2) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Interleukin-2 (IL-2) Forecast by Type
12.7 Global Human Interleukin-2 (IL-2) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.1.3 Roche Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 BMS
13.2.1 BMS Company Information
13.2.2 BMS Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.2.3 BMS Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BMS Main Business Overview
13.2.5 BMS Latest Developments
13.3 Schering-Plough
13.3.1 Schering-Plough Company Information
13.3.2 Schering-Plough Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.3.3 Schering-Plough Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Schering-Plough Main Business Overview
13.3.5 Schering-Plough Latest Developments
13.4 AbbVie Inc
13.4.1 AbbVie Inc Company Information
13.4.2 AbbVie Inc Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.4.3 AbbVie Inc Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AbbVie Inc Main Business Overview
13.4.5 AbbVie Inc Latest Developments
13.5 Alkermes Plc
13.5.1 Alkermes Plc Company Information
13.5.2 Alkermes Plc Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.5.3 Alkermes Plc Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Alkermes Plc Main Business Overview
13.5.5 Alkermes Plc Latest Developments
13.6 APT Therapeutics
13.6.1 APT Therapeutics Company Information
13.6.2 APT Therapeutics Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.6.3 APT Therapeutics Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 APT Therapeutics Main Business Overview
13.6.5 APT Therapeutics Latest Developments
13.7 Mabtech Limited
13.7.1 Mabtech Limited Company Information
13.7.2 Mabtech Limited Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.7.3 Mabtech Limited Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mabtech Limited Main Business Overview
13.7.5 Mabtech Limited Latest Developments
13.8 Philogen
13.8.1 Philogen Company Information
13.8.2 Philogen Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.8.3 Philogen Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Philogen Main Business Overview
13.8.5 Philogen Latest Developments
13.9 Sinopharm
13.9.1 Sinopharm Company Information
13.9.2 Sinopharm Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.9.3 Sinopharm Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sinopharm Main Business Overview
13.9.5 Sinopharm Latest Developments
13.10 Jiangsu Jinsili Pharmaceutical
13.10.1 Jiangsu Jinsili Pharmaceutical Company Information
13.10.2 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.10.3 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangsu Jinsili Pharmaceutical Main Business Overview
13.10.5 Jiangsu Jinsili Pharmaceutical Latest Developments
13.11 Shenyang Sansheng Pharmaceutical
13.11.1 Shenyang Sansheng Pharmaceutical Company Information
13.11.2 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.11.3 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shenyang Sansheng Pharmaceutical Main Business Overview
13.11.5 Shenyang Sansheng Pharmaceutical Latest Developments
13.12 Beijing Shuanglu Pharmaceutical
13.12.1 Beijing Shuanglu Pharmaceutical Company Information
13.12.2 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.12.3 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Beijing Shuanglu Pharmaceutical Main Business Overview
13.12.5 Beijing Shuanglu Pharmaceutical Latest Developments
13.13 Shandong Quangang Pharmaceutical
13.13.1 Shandong Quangang Pharmaceutical Company Information
13.13.2 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.13.3 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shandong Quangang Pharmaceutical Main Business Overview
13.13.5 Shandong Quangang Pharmaceutical Latest Developments
13.14 Shanghai Huaxin Biological high-tech
13.14.1 Shanghai Huaxin Biological high-tech Company Information
13.14.2 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.14.3 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shanghai Huaxin Biological high-tech Main Business Overview
13.14.5 Shanghai Huaxin Biological high-tech Latest Developments
13.15 Beijing Yuance Pharmaceutical
13.15.1 Beijing Yuance Pharmaceutical Company Information
13.15.2 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.15.3 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Beijing Yuance Pharmaceutical Main Business Overview
13.15.5 Beijing Yuance Pharmaceutical Latest Developments
13.16 Beijing Sihuan Biological Pharmaceutical
13.16.1 Beijing Sihuan Biological Pharmaceutical Company Information
13.16.2 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.16.3 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Beijing Sihuan Biological Pharmaceutical Main Business Overview
13.16.5 Beijing Sihuan Biological Pharmaceutical Latest Developments
13.17 Beijing Sanyuan Gene Pharmaceutical
13.17.1 Beijing Sanyuan Gene Pharmaceutical Company Information
13.17.2 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.17.3 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Beijing Sanyuan Gene Pharmaceutical Main Business Overview
13.17.5 Beijing Sanyuan Gene Pharmaceutical Latest Developments
13.18 Shenzhen Kexing Biological Engineering
13.18.1 Shenzhen Kexing Biological Engineering Company Information
13.18.2 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.18.3 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Shenzhen Kexing Biological Engineering Main Business Overview
13.18.5 Shenzhen Kexing Biological Engineering Latest Developments
13.19 Shanghai Sanwei Biotechnology
13.19.1 Shanghai Sanwei Biotechnology Company Information
13.19.2 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.19.3 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Shanghai Sanwei Biotechnology Main Business Overview
13.19.5 Shanghai Sanwei Biotechnology Latest Developments
13.20 Xiamen Tebao Biological Engineering
13.20.1 Xiamen Tebao Biological Engineering Company Information
13.20.2 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.20.3 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Xiamen Tebao Biological Engineering Main Business Overview
13.20.5 Xiamen Tebao Biological Engineering Latest Developments
13.21 Chengdu huashen Biotechnology
13.21.1 Chengdu huashen Biotechnology Company Information
13.21.2 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.21.3 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Chengdu huashen Biotechnology Main Business Overview
13.21.5 Chengdu huashen Biotechnology Latest Developments
13.22 Shanghai Pharma Group
13.22.1 Shanghai Pharma Group Company Information
13.22.2 Shanghai Pharma Group Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.22.3 Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Shanghai Pharma Group Main Business Overview
13.22.5 Shanghai Pharma Group Latest Developments
13.23 Guangdong Xinghao Pharmaceutical
13.23.1 Guangdong Xinghao Pharmaceutical Company Information
13.23.2 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
13.23.3 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Guangdong Xinghao Pharmaceutical Main Business Overview
13.23.5 Guangdong Xinghao Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Interleukin-2 (IL-2) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Human Interleukin-2 (IL-2) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 50000 U
Table 4. Major Players of 100000 U
Table 5. Major Players of 200000 U
Table 6. Major Players of 500000 U
Table 7. Major Players of 1 Million U
Table 8. Major Players of 2 Million U
Table 9. Global Human Interleukin-2 (IL-2) Sales by Type (2018-2023) & (KG)
Table 10. Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
Table 11. Global Human Interleukin-2 (IL-2) Revenue by Type (2018-2023) & ($ million)
Table 12. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2018-2023)
Table 13. Global Human Interleukin-2 (IL-2) Sale Price by Type (2018-2023) & (US$/G)
Table 14. Global Human Interleukin-2 (IL-2) Sales by Application (2018-2023) & (KG)
Table 15. Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2018-2023)
Table 16. Global Human Interleukin-2 (IL-2) Revenue by Application (2018-2023)
Table 17. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application (2018-2023)
Table 18. Global Human Interleukin-2 (IL-2) Sale Price by Application (2018-2023) & (US$/G)
Table 19. Global Human Interleukin-2 (IL-2) Sales by Company (2018-2023) & (KG)
Table 20. Global Human Interleukin-2 (IL-2) Sales Market Share by Company (2018-2023)
Table 21. Global Human Interleukin-2 (IL-2) Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Human Interleukin-2 (IL-2) Revenue Market Share by Company (2018-2023)
Table 23. Global Human Interleukin-2 (IL-2) Sale Price by Company (2018-2023) & (US$/G)
Table 24. Key Manufacturers Human Interleukin-2 (IL-2) Producing Area Distribution and Sales Area
Table 25. Players Human Interleukin-2 (IL-2) Products Offered
Table 26. Human Interleukin-2 (IL-2) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Human Interleukin-2 (IL-2) Sales by Geographic Region (2018-2023) & (KG)
Table 30. Global Human Interleukin-2 (IL-2) Sales Market Share Geographic Region (2018-2023)
Table 31. Global Human Interleukin-2 (IL-2) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Human Interleukin-2 (IL-2) Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Human Interleukin-2 (IL-2) Sales by Country/Region (2018-2023) & (KG)
Table 34. Global Human Interleukin-2 (IL-2) Sales Market Share by Country/Region (2018-2023)
Table 35. Global Human Interleukin-2 (IL-2) Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Human Interleukin-2 (IL-2) Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Human Interleukin-2 (IL-2) Sales by Country (2018-2023) & (KG)
Table 38. Americas Human Interleukin-2 (IL-2) Sales Market Share by Country (2018-2023)
Table 39. Americas Human Interleukin-2 (IL-2) Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Human Interleukin-2 (IL-2) Revenue Market Share by Country (2018-2023)
Table 41. Americas Human Interleukin-2 (IL-2) Sales by Type (2018-2023) & (KG)
Table 42. Americas Human Interleukin-2 (IL-2) Sales by Application (2018-2023) & (KG)
Table 43. APAC Human Interleukin-2 (IL-2) Sales by Region (2018-2023) & (KG)
Table 44. APAC Human Interleukin-2 (IL-2) Sales Market Share by Region (2018-2023)
Table 45. APAC Human Interleukin-2 (IL-2) Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Human Interleukin-2 (IL-2) Revenue Market Share by Region (2018-2023)
Table 47. APAC Human Interleukin-2 (IL-2) Sales by Type (2018-2023) & (KG)
Table 48. APAC Human Interleukin-2 (IL-2) Sales by Application (2018-2023) & (KG)
Table 49. Europe Human Interleukin-2 (IL-2) Sales by Country (2018-2023) & (KG)
Table 50. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country (2018-2023)
Table 51. Europe Human Interleukin-2 (IL-2) Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country (2018-2023)
Table 53. Europe Human Interleukin-2 (IL-2) Sales by Type (2018-2023) & (KG)
Table 54. Europe Human Interleukin-2 (IL-2) Sales by Application (2018-2023) & (KG)
Table 55. Middle East & Africa Human Interleukin-2 (IL-2) Sales by Country (2018-2023) & (KG)
Table 56. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Human Interleukin-2 (IL-2) Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Human Interleukin-2 (IL-2) Sales by Type (2018-2023) & (KG)
Table 60. Middle East & Africa Human Interleukin-2 (IL-2) Sales by Application (2018-2023) & (KG)
Table 61. Key Market Drivers & Growth Opportunities of Human Interleukin-2 (IL-2)
Table 62. Key Market Challenges & Risks of Human Interleukin-2 (IL-2)
Table 63. Key Industry Trends of Human Interleukin-2 (IL-2)
Table 64. Human Interleukin-2 (IL-2) Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Human Interleukin-2 (IL-2) Distributors List
Table 67. Human Interleukin-2 (IL-2) Customer List
Table 68. Global Human Interleukin-2 (IL-2) Sales Forecast by Region (2024-2029) & (KG)
Table 69. Global Human Interleukin-2 (IL-2) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Human Interleukin-2 (IL-2) Sales Forecast by Country (2024-2029) & (KG)
Table 71. Americas Human Interleukin-2 (IL-2) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Human Interleukin-2 (IL-2) Sales Forecast by Region (2024-2029) & (KG)
Table 73. APAC Human Interleukin-2 (IL-2) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Human Interleukin-2 (IL-2) Sales Forecast by Country (2024-2029) & (KG)
Table 75. Europe Human Interleukin-2 (IL-2) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Human Interleukin-2 (IL-2) Sales Forecast by Country (2024-2029) & (KG)
Table 77. Middle East & Africa Human Interleukin-2 (IL-2) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Human Interleukin-2 (IL-2) Sales Forecast by Type (2024-2029) & (KG)
Table 79. Global Human Interleukin-2 (IL-2) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Human Interleukin-2 (IL-2) Sales Forecast by Application (2024-2029) & (KG)
Table 81. Global Human Interleukin-2 (IL-2) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Roche Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 83. Roche Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 84. Roche Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 85. Roche Main Business
Table 86. Roche Latest Developments
Table 87. BMS Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 88. BMS Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 89. BMS Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 90. BMS Main Business
Table 91. BMS Latest Developments
Table 92. Schering-Plough Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 93. Schering-Plough Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 94. Schering-Plough Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 95. Schering-Plough Main Business
Table 96. Schering-Plough Latest Developments
Table 97. AbbVie Inc Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 98. AbbVie Inc Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 99. AbbVie Inc Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 100. AbbVie Inc Main Business
Table 101. AbbVie Inc Latest Developments
Table 102. Alkermes Plc Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 103. Alkermes Plc Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 104. Alkermes Plc Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 105. Alkermes Plc Main Business
Table 106. Alkermes Plc Latest Developments
Table 107. APT Therapeutics Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 108. APT Therapeutics Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 109. APT Therapeutics Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 110. APT Therapeutics Main Business
Table 111. APT Therapeutics Latest Developments
Table 112. Mabtech Limited Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 113. Mabtech Limited Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 114. Mabtech Limited Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 115. Mabtech Limited Main Business
Table 116. Mabtech Limited Latest Developments
Table 117. Philogen Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 118. Philogen Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 119. Philogen Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 120. Philogen Main Business
Table 121. Philogen Latest Developments
Table 122. Sinopharm Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 123. Sinopharm Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 124. Sinopharm Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 125. Sinopharm Main Business
Table 126. Sinopharm Latest Developments
Table 127. Jiangsu Jinsili Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 129. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 130. Jiangsu Jinsili Pharmaceutical Main Business
Table 131. Jiangsu Jinsili Pharmaceutical Latest Developments
Table 132. Shenyang Sansheng Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 133. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 134. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 135. Shenyang Sansheng Pharmaceutical Main Business
Table 136. Shenyang Sansheng Pharmaceutical Latest Developments
Table 137. Beijing Shuanglu Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 138. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 139. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 140. Beijing Shuanglu Pharmaceutical Main Business
Table 141. Beijing Shuanglu Pharmaceutical Latest Developments
Table 142. Shandong Quangang Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 143. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 144. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 145. Shandong Quangang Pharmaceutical Main Business
Table 146. Shandong Quangang Pharmaceutical Latest Developments
Table 147. Shanghai Huaxin Biological high-tech Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 148. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 149. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 150. Shanghai Huaxin Biological high-tech Main Business
Table 151. Shanghai Huaxin Biological high-tech Latest Developments
Table 152. Beijing Yuance Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 153. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 154. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 155. Beijing Yuance Pharmaceutical Main Business
Table 156. Beijing Yuance Pharmaceutical Latest Developments
Table 157. Beijing Sihuan Biological Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 158. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 159. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 160. Beijing Sihuan Biological Pharmaceutical Main Business
Table 161. Beijing Sihuan Biological Pharmaceutical Latest Developments
Table 162. Beijing Sanyuan Gene Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 163. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 164. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 165. Beijing Sanyuan Gene Pharmaceutical Main Business
Table 166. Beijing Sanyuan Gene Pharmaceutical Latest Developments
Table 167. Shenzhen Kexing Biological Engineering Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 168. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 169. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 170. Shenzhen Kexing Biological Engineering Main Business
Table 171. Shenzhen Kexing Biological Engineering Latest Developments
Table 172. Shanghai Sanwei Biotechnology Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 173. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 174. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 175. Shanghai Sanwei Biotechnology Main Business
Table 176. Shanghai Sanwei Biotechnology Latest Developments
Table 177. Xiamen Tebao Biological Engineering Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 178. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 179. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 180. Xiamen Tebao Biological Engineering Main Business
Table 181. Xiamen Tebao Biological Engineering Latest Developments
Table 182. Chengdu huashen Biotechnology Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 183. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 184. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 185. Chengdu huashen Biotechnology Main Business
Table 186. Chengdu huashen Biotechnology Latest Developments
Table 187. Shanghai Pharma Group Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 188. Shanghai Pharma Group Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 189. Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 190. Shanghai Pharma Group Main Business
Table 191. Shanghai Pharma Group Latest Developments
Table 192. Guangdong Xinghao Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 193. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 194. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 195. Guangdong Xinghao Pharmaceutical Main Business
Table 196. Guangdong Xinghao Pharmaceutical Latest Developments
Table 1. Human Interleukin-2 (IL-2) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Human Interleukin-2 (IL-2) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 50000 U
Table 4. Major Players of 100000 U
Table 5. Major Players of 200000 U
Table 6. Major Players of 500000 U
Table 7. Major Players of 1 Million U
Table 8. Major Players of 2 Million U
Table 9. Global Human Interleukin-2 (IL-2) Sales by Type (2018-2023) & (KG)
Table 10. Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
Table 11. Global Human Interleukin-2 (IL-2) Revenue by Type (2018-2023) & ($ million)
Table 12. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2018-2023)
Table 13. Global Human Interleukin-2 (IL-2) Sale Price by Type (2018-2023) & (US$/G)
Table 14. Global Human Interleukin-2 (IL-2) Sales by Application (2018-2023) & (KG)
Table 15. Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2018-2023)
Table 16. Global Human Interleukin-2 (IL-2) Revenue by Application (2018-2023)
Table 17. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application (2018-2023)
Table 18. Global Human Interleukin-2 (IL-2) Sale Price by Application (2018-2023) & (US$/G)
Table 19. Global Human Interleukin-2 (IL-2) Sales by Company (2018-2023) & (KG)
Table 20. Global Human Interleukin-2 (IL-2) Sales Market Share by Company (2018-2023)
Table 21. Global Human Interleukin-2 (IL-2) Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Human Interleukin-2 (IL-2) Revenue Market Share by Company (2018-2023)
Table 23. Global Human Interleukin-2 (IL-2) Sale Price by Company (2018-2023) & (US$/G)
Table 24. Key Manufacturers Human Interleukin-2 (IL-2) Producing Area Distribution and Sales Area
Table 25. Players Human Interleukin-2 (IL-2) Products Offered
Table 26. Human Interleukin-2 (IL-2) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Human Interleukin-2 (IL-2) Sales by Geographic Region (2018-2023) & (KG)
Table 30. Global Human Interleukin-2 (IL-2) Sales Market Share Geographic Region (2018-2023)
Table 31. Global Human Interleukin-2 (IL-2) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Human Interleukin-2 (IL-2) Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Human Interleukin-2 (IL-2) Sales by Country/Region (2018-2023) & (KG)
Table 34. Global Human Interleukin-2 (IL-2) Sales Market Share by Country/Region (2018-2023)
Table 35. Global Human Interleukin-2 (IL-2) Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Human Interleukin-2 (IL-2) Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Human Interleukin-2 (IL-2) Sales by Country (2018-2023) & (KG)
Table 38. Americas Human Interleukin-2 (IL-2) Sales Market Share by Country (2018-2023)
Table 39. Americas Human Interleukin-2 (IL-2) Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Human Interleukin-2 (IL-2) Revenue Market Share by Country (2018-2023)
Table 41. Americas Human Interleukin-2 (IL-2) Sales by Type (2018-2023) & (KG)
Table 42. Americas Human Interleukin-2 (IL-2) Sales by Application (2018-2023) & (KG)
Table 43. APAC Human Interleukin-2 (IL-2) Sales by Region (2018-2023) & (KG)
Table 44. APAC Human Interleukin-2 (IL-2) Sales Market Share by Region (2018-2023)
Table 45. APAC Human Interleukin-2 (IL-2) Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Human Interleukin-2 (IL-2) Revenue Market Share by Region (2018-2023)
Table 47. APAC Human Interleukin-2 (IL-2) Sales by Type (2018-2023) & (KG)
Table 48. APAC Human Interleukin-2 (IL-2) Sales by Application (2018-2023) & (KG)
Table 49. Europe Human Interleukin-2 (IL-2) Sales by Country (2018-2023) & (KG)
Table 50. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country (2018-2023)
Table 51. Europe Human Interleukin-2 (IL-2) Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country (2018-2023)
Table 53. Europe Human Interleukin-2 (IL-2) Sales by Type (2018-2023) & (KG)
Table 54. Europe Human Interleukin-2 (IL-2) Sales by Application (2018-2023) & (KG)
Table 55. Middle East & Africa Human Interleukin-2 (IL-2) Sales by Country (2018-2023) & (KG)
Table 56. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Human Interleukin-2 (IL-2) Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Human Interleukin-2 (IL-2) Sales by Type (2018-2023) & (KG)
Table 60. Middle East & Africa Human Interleukin-2 (IL-2) Sales by Application (2018-2023) & (KG)
Table 61. Key Market Drivers & Growth Opportunities of Human Interleukin-2 (IL-2)
Table 62. Key Market Challenges & Risks of Human Interleukin-2 (IL-2)
Table 63. Key Industry Trends of Human Interleukin-2 (IL-2)
Table 64. Human Interleukin-2 (IL-2) Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Human Interleukin-2 (IL-2) Distributors List
Table 67. Human Interleukin-2 (IL-2) Customer List
Table 68. Global Human Interleukin-2 (IL-2) Sales Forecast by Region (2024-2029) & (KG)
Table 69. Global Human Interleukin-2 (IL-2) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Human Interleukin-2 (IL-2) Sales Forecast by Country (2024-2029) & (KG)
Table 71. Americas Human Interleukin-2 (IL-2) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Human Interleukin-2 (IL-2) Sales Forecast by Region (2024-2029) & (KG)
Table 73. APAC Human Interleukin-2 (IL-2) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Human Interleukin-2 (IL-2) Sales Forecast by Country (2024-2029) & (KG)
Table 75. Europe Human Interleukin-2 (IL-2) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Human Interleukin-2 (IL-2) Sales Forecast by Country (2024-2029) & (KG)
Table 77. Middle East & Africa Human Interleukin-2 (IL-2) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Human Interleukin-2 (IL-2) Sales Forecast by Type (2024-2029) & (KG)
Table 79. Global Human Interleukin-2 (IL-2) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Human Interleukin-2 (IL-2) Sales Forecast by Application (2024-2029) & (KG)
Table 81. Global Human Interleukin-2 (IL-2) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Roche Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 83. Roche Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 84. Roche Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 85. Roche Main Business
Table 86. Roche Latest Developments
Table 87. BMS Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 88. BMS Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 89. BMS Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 90. BMS Main Business
Table 91. BMS Latest Developments
Table 92. Schering-Plough Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 93. Schering-Plough Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 94. Schering-Plough Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 95. Schering-Plough Main Business
Table 96. Schering-Plough Latest Developments
Table 97. AbbVie Inc Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 98. AbbVie Inc Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 99. AbbVie Inc Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 100. AbbVie Inc Main Business
Table 101. AbbVie Inc Latest Developments
Table 102. Alkermes Plc Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 103. Alkermes Plc Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 104. Alkermes Plc Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 105. Alkermes Plc Main Business
Table 106. Alkermes Plc Latest Developments
Table 107. APT Therapeutics Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 108. APT Therapeutics Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 109. APT Therapeutics Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 110. APT Therapeutics Main Business
Table 111. APT Therapeutics Latest Developments
Table 112. Mabtech Limited Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 113. Mabtech Limited Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 114. Mabtech Limited Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 115. Mabtech Limited Main Business
Table 116. Mabtech Limited Latest Developments
Table 117. Philogen Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 118. Philogen Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 119. Philogen Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 120. Philogen Main Business
Table 121. Philogen Latest Developments
Table 122. Sinopharm Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 123. Sinopharm Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 124. Sinopharm Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 125. Sinopharm Main Business
Table 126. Sinopharm Latest Developments
Table 127. Jiangsu Jinsili Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 129. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 130. Jiangsu Jinsili Pharmaceutical Main Business
Table 131. Jiangsu Jinsili Pharmaceutical Latest Developments
Table 132. Shenyang Sansheng Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 133. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 134. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 135. Shenyang Sansheng Pharmaceutical Main Business
Table 136. Shenyang Sansheng Pharmaceutical Latest Developments
Table 137. Beijing Shuanglu Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 138. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 139. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 140. Beijing Shuanglu Pharmaceutical Main Business
Table 141. Beijing Shuanglu Pharmaceutical Latest Developments
Table 142. Shandong Quangang Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 143. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 144. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 145. Shandong Quangang Pharmaceutical Main Business
Table 146. Shandong Quangang Pharmaceutical Latest Developments
Table 147. Shanghai Huaxin Biological high-tech Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 148. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 149. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 150. Shanghai Huaxin Biological high-tech Main Business
Table 151. Shanghai Huaxin Biological high-tech Latest Developments
Table 152. Beijing Yuance Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 153. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 154. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 155. Beijing Yuance Pharmaceutical Main Business
Table 156. Beijing Yuance Pharmaceutical Latest Developments
Table 157. Beijing Sihuan Biological Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 158. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 159. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 160. Beijing Sihuan Biological Pharmaceutical Main Business
Table 161. Beijing Sihuan Biological Pharmaceutical Latest Developments
Table 162. Beijing Sanyuan Gene Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 163. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 164. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 165. Beijing Sanyuan Gene Pharmaceutical Main Business
Table 166. Beijing Sanyuan Gene Pharmaceutical Latest Developments
Table 167. Shenzhen Kexing Biological Engineering Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 168. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 169. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 170. Shenzhen Kexing Biological Engineering Main Business
Table 171. Shenzhen Kexing Biological Engineering Latest Developments
Table 172. Shanghai Sanwei Biotechnology Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 173. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 174. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 175. Shanghai Sanwei Biotechnology Main Business
Table 176. Shanghai Sanwei Biotechnology Latest Developments
Table 177. Xiamen Tebao Biological Engineering Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 178. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 179. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 180. Xiamen Tebao Biological Engineering Main Business
Table 181. Xiamen Tebao Biological Engineering Latest Developments
Table 182. Chengdu huashen Biotechnology Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 183. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 184. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 185. Chengdu huashen Biotechnology Main Business
Table 186. Chengdu huashen Biotechnology Latest Developments
Table 187. Shanghai Pharma Group Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 188. Shanghai Pharma Group Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 189. Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 190. Shanghai Pharma Group Main Business
Table 191. Shanghai Pharma Group Latest Developments
Table 192. Guangdong Xinghao Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors
Table 193. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Product Portfolios and Specifications
Table 194. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 195. Guangdong Xinghao Pharmaceutical Main Business
Table 196. Guangdong Xinghao Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Interleukin-2 (IL-2)
Figure 2. Human Interleukin-2 (IL-2) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Interleukin-2 (IL-2) Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Human Interleukin-2 (IL-2) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Human Interleukin-2 (IL-2) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 50000 U
Figure 10. Product Picture of 100000 U
Figure 11. Product Picture of 200000 U
Figure 12. Product Picture of 500000 U
Figure 13. Product Picture of 1 Million U
Figure 14. Product Picture of 2 Million U
Figure 15. Global Human Interleukin-2 (IL-2) Sales Market Share by Type in 2022
Figure 16. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2018-2023)
Figure 17. Human Interleukin-2 (IL-2) Consumed in Recombinant Interferon
Figure 18. Global Human Interleukin-2 (IL-2) Market: Recombinant Interferon (2018-2023) & (KG)
Figure 19. Human Interleukin-2 (IL-2) Consumed in Recombinant Interleukin
Figure 20. Global Human Interleukin-2 (IL-2) Market: Recombinant Interleukin (2018-2023) & (KG)
Figure 21. Human Interleukin-2 (IL-2) Consumed in Natural Biological Products
Figure 22. Global Human Interleukin-2 (IL-2) Market: Natural Biological Products (2018-2023) & (KG)
Figure 23. Human Interleukin-2 (IL-2) Consumed in Poison Immune
Figure 24. Global Human Interleukin-2 (IL-2) Market: Poison Immune (2018-2023) & (KG)
Figure 25. Human Interleukin-2 (IL-2) Consumed in Gene Therapy
Figure 26. Global Human Interleukin-2 (IL-2) Market: Gene Therapy (2018-2023) & (KG)
Figure 27. Human Interleukin-2 (IL-2) Consumed in Monoclonal Antibody
Figure 28. Global Human Interleukin-2 (IL-2) Market: Monoclonal Antibody (2018-2023) & (KG)
Figure 29. Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2022)
Figure 30. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application in 2022
Figure 31. Human Interleukin-2 (IL-2) Sales Market by Company in 2022 (KG)
Figure 32. Global Human Interleukin-2 (IL-2) Sales Market Share by Company in 2022
Figure 33. Human Interleukin-2 (IL-2) Revenue Market by Company in 2022 ($ Million)
Figure 34. Global Human Interleukin-2 (IL-2) Revenue Market Share by Company in 2022
Figure 35. Global Human Interleukin-2 (IL-2) Sales Market Share by Geographic Region (2018-2023)
Figure 36. Global Human Interleukin-2 (IL-2) Revenue Market Share by Geographic Region in 2022
Figure 37. Americas Human Interleukin-2 (IL-2) Sales 2018-2023 (KG)
Figure 38. Americas Human Interleukin-2 (IL-2) Revenue 2018-2023 ($ Millions)
Figure 39. APAC Human Interleukin-2 (IL-2) Sales 2018-2023 (KG)
Figure 40. APAC Human Interleukin-2 (IL-2) Revenue 2018-2023 ($ Millions)
Figure 41. Europe Human Interleukin-2 (IL-2) Sales 2018-2023 (KG)
Figure 42. Europe Human Interleukin-2 (IL-2) Revenue 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Human Interleukin-2 (IL-2) Sales 2018-2023 (KG)
Figure 44. Middle East & Africa Human Interleukin-2 (IL-2) Revenue 2018-2023 ($ Millions)
Figure 45. Americas Human Interleukin-2 (IL-2) Sales Market Share by Country in 2022
Figure 46. Americas Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2022
Figure 47. Americas Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
Figure 48. Americas Human Interleukin-2 (IL-2) Sales Market Share by Application (2018-2023)
Figure 49. United States Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Canada Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 51. Mexico Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Brazil Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 53. APAC Human Interleukin-2 (IL-2) Sales Market Share by Region in 2022
Figure 54. APAC Human Interleukin-2 (IL-2) Revenue Market Share by Regions in 2022
Figure 55. APAC Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
Figure 56. APAC Human Interleukin-2 (IL-2) Sales Market Share by Application (2018-2023)
Figure 57. China Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 58. Japan Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 59. South Korea Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Southeast Asia Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 61. India Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Australia Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 63. China Taiwan Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country in 2022
Figure 65. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2022
Figure 66. Europe Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
Figure 67. Europe Human Interleukin-2 (IL-2) Sales Market Share by Application (2018-2023)
Figure 68. Germany Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 69. France Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 70. UK Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Italy Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Russia Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Country in 2022
Figure 74. Middle East & Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2022
Figure 75. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
Figure 76. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Application (2018-2023)
Figure 77. Egypt Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 78. South Africa Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 79. Israel Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 80. Turkey Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 81. GCC Country Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 82. Manufacturing Cost Structure Analysis of Human Interleukin-2 (IL-2) in 2022
Figure 83. Manufacturing Process Analysis of Human Interleukin-2 (IL-2)
Figure 84. Industry Chain Structure of Human Interleukin-2 (IL-2)
Figure 85. Channels of Distribution
Figure 86. Global Human Interleukin-2 (IL-2) Sales Market Forecast by Region (2024-2029)
Figure 87. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Region (2024-2029)
Figure 88. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Type (2024-2029)
Figure 89. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Type (2024-2029)
Figure 90. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Application (2024-2029)
Figure 91. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Human Interleukin-2 (IL-2)
Figure 2. Human Interleukin-2 (IL-2) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Interleukin-2 (IL-2) Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Human Interleukin-2 (IL-2) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Human Interleukin-2 (IL-2) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 50000 U
Figure 10. Product Picture of 100000 U
Figure 11. Product Picture of 200000 U
Figure 12. Product Picture of 500000 U
Figure 13. Product Picture of 1 Million U
Figure 14. Product Picture of 2 Million U
Figure 15. Global Human Interleukin-2 (IL-2) Sales Market Share by Type in 2022
Figure 16. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2018-2023)
Figure 17. Human Interleukin-2 (IL-2) Consumed in Recombinant Interferon
Figure 18. Global Human Interleukin-2 (IL-2) Market: Recombinant Interferon (2018-2023) & (KG)
Figure 19. Human Interleukin-2 (IL-2) Consumed in Recombinant Interleukin
Figure 20. Global Human Interleukin-2 (IL-2) Market: Recombinant Interleukin (2018-2023) & (KG)
Figure 21. Human Interleukin-2 (IL-2) Consumed in Natural Biological Products
Figure 22. Global Human Interleukin-2 (IL-2) Market: Natural Biological Products (2018-2023) & (KG)
Figure 23. Human Interleukin-2 (IL-2) Consumed in Poison Immune
Figure 24. Global Human Interleukin-2 (IL-2) Market: Poison Immune (2018-2023) & (KG)
Figure 25. Human Interleukin-2 (IL-2) Consumed in Gene Therapy
Figure 26. Global Human Interleukin-2 (IL-2) Market: Gene Therapy (2018-2023) & (KG)
Figure 27. Human Interleukin-2 (IL-2) Consumed in Monoclonal Antibody
Figure 28. Global Human Interleukin-2 (IL-2) Market: Monoclonal Antibody (2018-2023) & (KG)
Figure 29. Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2022)
Figure 30. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application in 2022
Figure 31. Human Interleukin-2 (IL-2) Sales Market by Company in 2022 (KG)
Figure 32. Global Human Interleukin-2 (IL-2) Sales Market Share by Company in 2022
Figure 33. Human Interleukin-2 (IL-2) Revenue Market by Company in 2022 ($ Million)
Figure 34. Global Human Interleukin-2 (IL-2) Revenue Market Share by Company in 2022
Figure 35. Global Human Interleukin-2 (IL-2) Sales Market Share by Geographic Region (2018-2023)
Figure 36. Global Human Interleukin-2 (IL-2) Revenue Market Share by Geographic Region in 2022
Figure 37. Americas Human Interleukin-2 (IL-2) Sales 2018-2023 (KG)
Figure 38. Americas Human Interleukin-2 (IL-2) Revenue 2018-2023 ($ Millions)
Figure 39. APAC Human Interleukin-2 (IL-2) Sales 2018-2023 (KG)
Figure 40. APAC Human Interleukin-2 (IL-2) Revenue 2018-2023 ($ Millions)
Figure 41. Europe Human Interleukin-2 (IL-2) Sales 2018-2023 (KG)
Figure 42. Europe Human Interleukin-2 (IL-2) Revenue 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Human Interleukin-2 (IL-2) Sales 2018-2023 (KG)
Figure 44. Middle East & Africa Human Interleukin-2 (IL-2) Revenue 2018-2023 ($ Millions)
Figure 45. Americas Human Interleukin-2 (IL-2) Sales Market Share by Country in 2022
Figure 46. Americas Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2022
Figure 47. Americas Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
Figure 48. Americas Human Interleukin-2 (IL-2) Sales Market Share by Application (2018-2023)
Figure 49. United States Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Canada Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 51. Mexico Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Brazil Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 53. APAC Human Interleukin-2 (IL-2) Sales Market Share by Region in 2022
Figure 54. APAC Human Interleukin-2 (IL-2) Revenue Market Share by Regions in 2022
Figure 55. APAC Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
Figure 56. APAC Human Interleukin-2 (IL-2) Sales Market Share by Application (2018-2023)
Figure 57. China Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 58. Japan Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 59. South Korea Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Southeast Asia Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 61. India Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Australia Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 63. China Taiwan Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country in 2022
Figure 65. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2022
Figure 66. Europe Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
Figure 67. Europe Human Interleukin-2 (IL-2) Sales Market Share by Application (2018-2023)
Figure 68. Germany Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 69. France Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 70. UK Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Italy Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Russia Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Country in 2022
Figure 74. Middle East & Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2022
Figure 75. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Type (2018-2023)
Figure 76. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Application (2018-2023)
Figure 77. Egypt Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 78. South Africa Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 79. Israel Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 80. Turkey Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 81. GCC Country Human Interleukin-2 (IL-2) Revenue Growth 2018-2023 ($ Millions)
Figure 82. Manufacturing Cost Structure Analysis of Human Interleukin-2 (IL-2) in 2022
Figure 83. Manufacturing Process Analysis of Human Interleukin-2 (IL-2)
Figure 84. Industry Chain Structure of Human Interleukin-2 (IL-2)
Figure 85. Channels of Distribution
Figure 86. Global Human Interleukin-2 (IL-2) Sales Market Forecast by Region (2024-2029)
Figure 87. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Region (2024-2029)
Figure 88. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Type (2024-2029)
Figure 89. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Type (2024-2029)
Figure 90. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Application (2024-2029)
Figure 91. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Application (2024-2029)
